PTC Therapeutics reported strong Q3 2026 results with total revenue of $358 million, including $276 million from product sales, led by the Sephience launch. The company raised its full-year 2026 revenue guidance to $1.29-$1.32 billion, with product revenue expected between $960-$990 million. Key developments include the acquisition of the ST-920 gene therapy for Fabry disease, with a BLA submission expected in Q4 2026, and progress in multiple clinical programs. Despite a net loss of $51.7 million in Q3, PTC remains on track for cash flow breakeven and continued growth globally.
PTC Therapeutics' Q3 2026 financial results provide context for readers. For those tracking the health sector, 94 of 150 US health stocks on Pluang rose while 55 fell as of Oct 30, 2026 02:11 WIB. Notable movers include Inovio Pharmaceuticals Inc (INO) down 15.13% at USD 0.79, Haleon plc (HLN) down 14.80% at USD 8.52 with 100% buy order activity, and Nuwellis Inc (NUWE) up 14.34% at USD 6.46 with 55% buy order activity.
iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...
Ipsos has appointed Mitch Barns as Chairman and CEO for the Americas region, effective November 2, 2026. Barns brings extensive leadership experience from his previous roles as Global CEO of Nielsen and CEO of The Opus Group, positioning him to drive...
SAP, a global enterprise software leader, will merge its North Texas operations into a new office in Addison, Texas, relocating about 1,000 employees from Plano and Allen. The new Spectrum Center location will house business operations, software deve...
Two large transfers totaling 346.2 million Tether (USDT) occurred on October 29, moving 132.4 million USDT on the Tron network and 213.8 million USDT on Ethereum just five seconds apart. The transaction details do not indicate whether these transfers...
Smithfield Foods, a leading American food company specializing in packaged meats and fresh pork, announced a quarterly dividend of $0.3125 per share. The dividend will be paid on November 25, 2026, to shareholders recorded by November 12, 2026. This ...
